Comprehensive functional annotation of 18 missense mutations found in suspected hemochromatosis type 4 patients

Isabelle Callebaut1, Rozenn Joubrel2, Serge Pissard3

  • 1IMPMC, Sorbonne Universités - UMR CNRS 7590, UPMC Univ Paris 06, Muséum d'Histoire Naturelle, IRD UMR 206, Paris, France.

Insights

This study clarifies genetic mutations in ferroportin 1 (SLC40A1) causing hemochromatosis type 4. It distinguishes loss-of-function and gain-of-function variants, improving diagnosis and patient management for iron overload disorders.

Area of Science:

  • Genetics
  • Molecular Biology
  • Biochemistry

Background:

  • Hemochromatosis type 4 is a rare autosomal dominant iron overload disorder.
  • It stems from mutations in the ferroportin 1 gene (SLC40A1).
  • Mutations cause either loss-of-function or gain-of-function, leading to distinct clinical subtypes (4A and 4B).

Purpose of the Study:

  • To investigate the causality of SLC40A1 missense variants in hemochromatosis type 4.
  • To differentiate between loss-of-function and gain-of-function mutations.
  • To understand the structural and functional impact of these mutations on ferroportin.

Main Methods:

  • Integrated analysis of genetic and phenotypic data from 44 patients.
  • In silico structural and functional annotations.
  • Biochemical assays to assess protein function and expression.

Main Results:

  • Causality confirmed for 10 missense variants, clearly separating type 4A and 4B.
  • Identified two subgroups of loss-of-function mutations: impaired cell-surface expression and altered iron egress.
  • Discovered a new gain-of-function mutation and elucidated ferroportin degradation mechanisms.
  • Eight variants showed no discernible effect, associated with milder phenotypes.

Conclusions:

  • Combining in silico and biochemical methods is crucial for distinguishing pathogenic SLC40A1 mutations from benign variants.
  • Accurate mutation identification has significant implications for patient diagnosis and management.
  • The study refines the understanding of ferroportin function and its role in iron overload.